Murphy Oil's 2026 Capex Plan: Bubale Appraisal Meets Eagle Ford Funding Discipline

Murphy's 2026 Capex Plan Puts Bubale Under the Microscope

Murphy has signaled full-year 2026 capital expenditures to increase after Bubale-1X discovery offshore Côte d'Ivoire. That shifts the market's focus from exploration excitement to capital allocation: can the company fund appraisal without overstretching the rest of the portfolio?

The quarter showed the trade-off clearly. Murphy generated $41.4 million in free cash flow in the first quarter, leaving limited room for error as it advances Bubale and other projects. In the second quarter, capex rose to $476.0 million. The key bull argument is that mature assets can fund appraisal and, if the reservoir proves out, future development. The bear case is that spending is rising before Bubale has any production or reserve support.

For now, the setup looks more like an appraisal trade than a fully de-risked growth story. The next few months matter because investors need evidence that Bubale can justify the added spend.

Bubale Has Upside, but the Mature Portfolio Still Has to Fund It

The basic structure is simple: Bubale is the upside option, while the producing base is still expected to carry the funding burden. That matters because exploration can change the narrative quickly, but development only becomes credible after dry-hole risk has already been absorbed by cash-generating assets.

The discovery is real, but the case still needs appraisal

Management said Bubale-1X encountered 100 feet of net oil pay across two reservoirs, and the company has first appraisal well already underway. That is enough to keep the project on investors' radars. It is not yet enough to remove execution and reservoir risk.

The cost of that proof is already visible. Murphy reported $163 million of exploration expenses in the first quarter, including $67 million related to unsuccessful wells in Côte d'Ivoire. The point is not that Bubale is a bad prospect; it is that the company is still spending heavily to build the development case, not harvesting cash from the discovery itself.

That dynamic will determine how the market values the story. If the mature portfolio continues to generate strong cash flow, Bubale can stay on the critical path and potentially earn its place in the plan. If not, the discovery risks looking more like a drain on capital elsewhere than a near-term value driver.

Balance-sheet flexibility has bought time, not validation

This has not become a credit story because Murphy entered this phase with a durable funding position. The company reported 1.1x leverage and $2.38 billion of liquidity, with no drawings under the senior unsecured credit facility. That gives management room to appraise Bubale without an immediate funding crisis.

But flexibility is not the same as reservoir validation. It only buys time to test whether the discovery can expand into an investable field.

What Would Make MUR More Constructive?

Treat MUR as an appraisal trade until the geology and funding story line up more clearly. The stock can remain interesting on optionality, but a stronger rerating likely needs proof that Bubale is becoming a real field rather than staying a promising discovery.

The trigger to get more constructive

The bull case becomes more credible when two conditions happen together:

• Bubale appraisal starts reducing geological and sizing risk.
• The mature portfolio continues to fund the program without pressuring the balance sheet.

That combination would show that the discovery is being de-risked by execution, not just by exploration success.

What to watch now

Watch whether each new Bubale well expands the investable case in a measurable way. Also watch whether the base portfolio keeps delivering the cash flow and operational stability Murphy needs to support the wider program.

The setup weakens if appraisal progress drags on without clear reservoir updates, or if the mature portfolio loses the ability to support additional spending. That risk is easier to monitor because Murphy is not under immediate funding pressure: it has 1.1x leverage, $2.38 billion of liquidity, and no drawings under the senior unsecured credit facility.

For now, the opportunity is still about verified upside. If appraisal adds scale and the producing base keeps showing up, MUR can start to trade less like a story stock and more like a portfolio with proven funding behind its next major discovery.